Elissa S. Cote's most recent trade in VistaGen Therapeutics Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VistaGen Therapeutics Inc | Elissa S. Cote | Chief Corp Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |